The news of Wells Fargo maintaining an Equal-Weight rating on Nutanix and raising the price target from $32 to $35 indicates that the analyst sees potential in the stock but does not expect significant short-term price movement. This may not have a strong impact on the stock price in the short term, hence the neutral score.